Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05701254 · ClinicalTrials.gov registry record
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
A clinical trial of Type 1 Diabetes and Bone Loss, sponsored by Creighton University.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT05701254 is a study of Type 1 Diabetes and Bone Loss that is actively recruiting participants, run by Creighton University. The registered enrollment target is 80 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05701254, a study of Type 1 Diabetes and Bone Loss, is actively recruiting participants, sponsored by Creighton University.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with Type 1 Diabetes Mellitus (T1DM) have a higher risk of low-trauma (osteoporotic) fracture that is 7-12 times higher than non-diabetics. The bone density of people with Type 1 Diabetes is higher at the time of fracture than in non-diabetics. This suggests the presence of underlying bone tissue mechanical defects. The potential benefits to participants would be knowledge gained about their bone density and the results of laboratory tests. On a wider scale, there may be general benefits to society because the knowledge gained from this study may help better understand the effects of diabetes on bone health
Conditions Studied
Interventions
- PROCEDURE Transilial bone biopsy
Study Locations (1)
Nebraska
- Creighton University Osteoporosis Research Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2025-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05701254
The ClinicalTrials.gov registry entry for NCT05701254 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (90% lower). The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Transilial bone biopsy is the first listed.
NCT05701254 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT05701254 about?
NCT05701254 is a clinical study titled "Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk". Patients with Type 1 Diabetes Mellitus (T1DM) have a higher risk of low-trauma (osteoporotic) fracture that is 7-12 times higher than non-diabetics. The bone density of people with Type 1 Diabetes is higher at the time of fracture than in non-diabetics. This suggests the presence of underlying bone ...
What is the current status of trial NCT05701254?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2019-06-18. Estimated completion is 2025-01.
What conditions does trial NCT05701254 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Bone Loss, Fractures, Bone, Osteopenia.
What interventions are being tested in trial NCT05701254?
The interventions under investigation include: Transilial bone biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05701254?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05701254 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
RECRUITING
-
Extended Bolus for Meals in a Closed-loop System
RECRUITING · Phase 4
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
AIDANET Pediatrics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.